Effect different doses of Surfactant (CUROSURF)

Comparison the effect and outcome of Surfactant (CUROSURF) with doses 100 & 200 mg/kg in neonates with respiratory distress syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210102049921N1

Enrollment

Registered

2021-05-31

Start date

2021-06-06

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress syndrome of newborn (RDS). Respiratory distress syndrome of newborn

Interventions

Intervention 1: Intervention group: Intratracheal injection of surfactant under the brand name Curosurf at a dose of 100 mg/kg made by Chiesi Farmaceutici factory(Italy). Intervention 2: Intervention

Eligibility

Sex/Gender

All

Age

No minimum to 2 Days

Inclusion criteria

Inclusion criteria: Neonates with respiratory distress syndrome Requires treatment with Surfactant

Exclusion criteria

Exclusion criteria: Cardiopulmonary resuscitation during labour

Design outcomes

Primary

Measure	Time frame
Duration of hospitalization. Timepoint: Daily. Method of measurement: Calendar.;Complications of treatment. Timepoint: Duration of hospitalization. Method of measurement: Chest-X-ray and clinical observation.;Requires a variety of auxiliary ventilation. Timepoint: every hour. Method of measurement: Digital clock.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Poorhoseiny

Birjand University of Medical Sciences

Reza.poorhoseiny52@bums.ac.ir+98 56 3162 2001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026